Vivacelle Bio Commemorates Sepsis Awareness Month, Recognizing the Leading Cause of Death in U.S. Hospitals

KANSAS CITY, Mo., Sept. 24, 2024 /PRNewswire/ -- Vivacelle Bio, a late-stage biopharma company developing life-saving treatments for shock and trauma, today announced its support of the Sepsis Alliance in its mission to raise awareness and understanding around sepsis. Sepsis, which is an overwhelming or impaired whole-body immune response to an infection or other insult, is the leading cause of death in U.S. hospitals, the cause of approximately 6% of all U.S. hospitalizations and 35% of all in-hospital deaths.1,

https://www.prnewswire.com/news-releases/vivacelle-bio-commemorates-sepsis-awareness-month-recognizing-the-leading-cause-of-death-in-us-hospitals-302255761.html?tc=eml_cleartime